Disclosed trades
20
since 2014
Estimated trade volumeMembers disclose each trade as a dollar range. We count each at the middle of its range, or at the bottom when the range has no top (a + follows the total then). An estimate, not an exact figure.
$454.0K
since 2014
Net worth estimate
From the 2025 annual disclosure
Committee seats
…
Latest campaign cycle
Raised in the 2026 cycle

Capitol Hires from Dina Titus’s office

4 hires

Lobbyists for public companies who say they once worked in Dina Titus’s office, from their lobbying filings.

Capitol Hires from Dina Titus's office
The lobbying report (LDA form LD-2) that names this lobbyist and office, with a link to it. Report period is the quarter the report covers; Posted is the day it was filed or amended, which can be much later. The same lobbyist is named again on each quarterly report for the same client, so a row is shown once, from the newest report, with the number of filings that name them.
AMGN
Amgen Inc.
Karen StoneLegislative DirectorCapitol Counsel LLC
Report period 2026 Q3 ↗
Posted Oct 19, 2026
BMY
Bristol-Myers Squibb Company
Karen StoneLegislative DirectorCapitol Counsel LLC
Report period 2026 Q2 ↗
Posted Jul 16, 2026
EBS
Emergent BioSolutions Inc.
Karen StoneLegislative DirectorCapitol Counsel LLC
Report period 2026 Q1 ↗
Posted Apr 15, 2026
NBIX
Neurocrine Biosciences, Inc.
Karen StoneSenior Legislative Assistant, ]Capitol Counsel LLC
Report period 2025 Q4 ↗
Posted Jan 18, 2026

Each row reflects what was disclosed at the time of filing. A lobbyist listed may no longer be registered.

← All members of Congress